Rudensky Symposium Honors a Legacy, Illuminates Frontiers in Immunity, Inflammation, and Tolerance
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, at the...
Knowledge and News for the Global Fight Against Cancer.
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, at the...
Glioblastoma, a relentless and aggressive form of brain cancer, continues to pose one of the...
Researchers at Baylor College of Medicine have developed an experimental drug named CS18, which shows...
Colorectal cancer has tragically become the leading cause of cancer-related death among people younger than...
T cell receptor therapy, known as TCR therapy, is a form of cancer treatment that...
Colorado-based emerging biotech firm Enveda Biosciences has announced the successful closure of a Series E...
Research published in the esteemed journal Regional Anesthesia & Pain Medicine indicates a significant correlation...
The harrowing journey of Jaylen and Ayla, two siblings diagnosed with hereditary bilateral retinoblastoma, serves...
September marks the annual observance of Childhood Cancer Awareness Month, a period dedicated to highlighting...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...